MedTrace Logo

Role of aGVHD Biomarkers on aGVHD Risks

NCT04284904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-05-05

No results posted yet for this study

Summary

To establish risk rating criteria of biological protein marker, determine the role and consistency of aGVHD biomarkers in aGVHD diagnosis and aGVHD prognosis, and evaluate the the impact on non-relapse mortality and relapse and disease free survival, the multicenter study on aGVHD biomarkers detection in the patients underwent allogeneic hematopoietic stem cell transplantation was performed.

Conditions

  • GVHD,Acute
  • Biomarker

Interventions

DIAGNOSTIC_TEST

aGVHD biomarker

To verify the effectiveness of aGVHD biomarkers monitoring in predicting aGVHD risks

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Daihong Liu · Chinese PLA General Hospital

Eligibility

Min Age
0 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04284904 on ClinicalTrials.gov